about
Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysisEffect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patientsPlacental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group boDietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.Co-Expression Analysis of Blood Cell Genome Expression to Preliminary Investigation of Regulatory Mechanisms in Uremia.Advanced glycation end product accumulation in rho(0) cells without a functional respiratory chain.Dietary consumption of advanced glycation end products and risk of metabolic syndrome.An association of cognitive impairment with diabetes and retinopathy in end stage renal disease patients under peritoneal dialysis.Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and AgingLow Glucose Degradation Product Peritoneal Dialysis Regimen Is Associated With Lower Plasma EN-RAGE and HMGB-1 Proinflammatory Ligands of Receptor for Advanced Glycation End Products
P2860
Q34023341-76DB8F38-2411-4E4B-A0AB-9AD1F587F495Q34362687-E8083BB8-D4A8-4745-B437-20EB11C27333Q34493096-D2D29282-CC1A-427C-B9A6-612D3B416958Q34706565-3A633867-C468-443E-9986-8DCECACB832CQ35451921-CAF8F27F-0916-4529-B19F-28AC15D6D534Q37072018-5C582814-EC17-470F-9DB3-B63282B4C87CQ37262909-CA3CAA8E-F8C9-47FA-954D-73536F593B28Q37482925-2DD7082F-A49C-420C-9C3B-5349937896C2Q37582744-51FE97E5-950B-4F97-B120-5A9D54CB489CQ39849641-55C22136-1EF2-44F7-8F70-619E0A7818B5Q40018926-24F11F25-6839-4FBA-8250-7629421CC4B2Q41576667-ABB465D9-2ADB-42F3-BEEA-860724DBDB05Q45339625-281AC9A1-6D98-46AA-B079-7AD597C36D3FQ57051319-BF835A08-DC00-4BC6-A406-E5EA362F8F1BQ57825113-DBD98DBC-9C8B-4DD2-84D4-FAC430E69DC0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Advanced glycation end products in renal failure.
@ast
Advanced glycation end products in renal failure.
@en
type
label
Advanced glycation end products in renal failure.
@ast
Advanced glycation end products in renal failure.
@en
prefLabel
Advanced glycation end products in renal failure.
@ast
Advanced glycation end products in renal failure.
@en
P1476
Advanced glycation end products in renal failure.
@en
P304
P356
10.1053/J.JRN.2006.04.012
P577
2006-07-01T00:00:00Z